CrossAmerica Partners
21.7.2026 22:20:00 CEST | Globenewswire | Press release
CrossAmerica Partners LP Maintains Quarterly Distribution
CrossAmerica Partners LP Maintains Quarterly Distribution
•Quarterly distribution of $0.5250 per unit attributable to the second quarter of 2026
Allentown, PA, July 21, 2026 (GLOBE NEWSWIRE) --
CrossAmerica Partners LP Maintains Quarterly Distribution
- Quarterly distribution of $0.5250 per unit attributable to the second quarter of 2026
ALLENTOWN, PA (July 21, 2026) – CrossAmerica Partners LP (NYSE: CAPL) announced today that the Board of Directors of its general partner has approved a quarterly distribution of $0.5250 per unit attributable to the second quarter of 2026 (annualized $2.10 per unit). The distribution attributable to the second quarter is payable on August 13, 2026, to all unitholders of record on August 3, 2026.
CrossAmerica will host a conference call on August 6th at 9:00 a.m. Eastern Time to discuss second quarter 2026 earnings results, which will be released after the market closes on Wednesday, August 5.
About CrossAmerica Partners LP
CrossAmerica Partners is a leading wholesale distributor of motor fuels, convenience store operator, and owner and lessor of real estate used in the retail distribution of motor fuels. Its general partner, CrossAmerica GP LLC, is indirectly owned and controlled by entities affiliated with Joseph V. Topper, Jr., the founder of CrossAmerica Partners and a member of the board of the general partner since 2012. Formed in 2012, CrossAmerica Partners LP is a distributor of branded and unbranded petroleum for motor vehicles in the United States and distributes fuel to approximately 1,500 locations and owns or leases approximately 900 sites. With a geographic footprint covering 34 states, the Partnership has well-established relationships with several major oil brands, including ExxonMobil, BP, Shell, Marathon, Valero, Phillips 66 and other major brands. CrossAmerica Partners ranks as one of ExxonMobil's largest distributors by fuel volume in the United States and in the top 10 for additional brands. For additional information, please visit www.crossamericapartners.com.
Forward Looking Statement
Statements contained in this release that state the Partnership’s or management's expectations or predictions of the future are forward-looking statements. The words "believe," "expect," "should," "intends," "estimates," "target," "plan" and other similar expressions identify forward-looking statements. It is important to note that actual results could differ materially from those projected in such forward-looking statements. For more information concerning factors that could cause actual results to differ from those expressed or forecasted, see CrossAmerica's Forms 10-Q or Form 10-K filed with the Securities and Exchange Commission and available on CrossAmerica's website at www.crossamericapartners.com. The Partnership undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
Note to Non-United States Investors: This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4. Brokers and nominees should treat one hundred percent (100%) of CrossAmerica Partners LP’s distributions to non-U.S. investors as attributable to income that is effectively connected with a United States trade or business. Accordingly, CrossAmerica Partners LP’s distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.
Contact – Randy Palmer, rpalmer@caplp.com or 610-625-8000
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Junshi Biosciences22.7.2026 01:10:13 CEST | Press release
Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC
Sanofi Winthrop Industrie21.7.2026 18:00:00 CEST | Press release
Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter
Bitget Limited21.7.2026 16:00:00 CEST | Press release
Bitget Emerges as a Leading TradFi Trading Venue With Nearly $70B in Q2 Perpetual Volume, TokenInsight Report Finds
Pure Data Centres21.7.2026 15:47:37 CEST | Press release
Pure DC Secures Additional €1.3 Billion to Accelerate Growth of One of Europe’s Largest AI Campuses
SK pharmteco Inc.21.7.2026 15:03:00 CEST | Press release
SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom